Trending:
News
-
26 April 2018
Natural barcode helps track cells for genetic information
Researchers in the US have devised a technique for genetic analysis that uses a 'natural barcode' to track what happens to cells when they are exposed to different experimental conditions.
-
26 April 2018
India teams up with World Bank to boost healthcare sector
The Government of India has entered a $125m agreement with the World Bank to advance the country's biopharmaceutical and medical devices industry.
-
26 April 2018
Nektar and Takeda to test combination regimen for cancer
Nektar Therapeutics has entered into a clinical collaboration to investigate its NKTR-214 drug candidate in combination with Takeda Pharmaceutical’s TAK-659 for various types of cancer.
-
25 April 2018
Research shows differences in orphan drug availability in Europe
A study suggests that the availability of orphan drugs varies significantly between different countries in Europe.
-
25 April 2018
World Malaria Day: WHO spotlights global health campaign
World Malaria Day, an annual event that recognises global efforts to control malaria, takes place on 25 April. This year, the World Health Organisation (WHO), along with partner organisations, is...
-
25 April 2018
Tweaking diabetes treatments can improve effectiveness
Research carried out by Imperial College London has showed that small alterations to existing diabetes treatments can increase their effectiveness by changing their interactions with cells.
-
25 April 2018
Topas partners with Boehringer for vector-based drugs
German biotechnology company Topas Therapeutics has partnered with Boehringer Ingelheim to focus on antigen-specific tolerance induction to tackle anti-drug antibodies (ADA).
-
25 April 2018
Fish protein may reduce Parkinson’s disease risk
Researchers from Chalmers University of Technology in Sweden have discovered that eating fish can prevent formation of some protein structures associated with Parkinson’s disease.
-
24 April 2018
Takeda makes fourth offer of £44.3bn for Shire takeover
Takeda Pharmaceutical Company has put forward a fourth offer to acquire Shire, a day after the Irish biopharmaceutical company best known for ADHD drug Adderall rejected a previous offer.
-
24 April 2018
Biogen and Ionis to develop neurological drugs in $1bn deal
Biogen has formed a strategic alliance worth $1bn with Ionis Pharmaceuticals to develop a pipeline of drug candidates for multiple neurological diseases.
